Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shan Goh

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|July 19, 2023
Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBBZi Wei Chang, Yun Shan Goh, Angeline Rouers, et al.
The Journal of Infectious Diseases|November 23, 2023
Variant-Specific IgA Protects Against Omicron InfectionYun Shan Goh, Siew-Wai Fong, Pei Xiang Hor, et al.
Lancet (London, England)|August 22, 2020
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort studyBarnaby E Young, Siew-Wai Fong, Yi-Hao Chan, et al.
The Lancet Regional Health. Western Pacific|September 27, 2021
Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in AsiansBei Wang, Yun Shan Goh, Siew-Wai Fong, et al.
Vaccine|September 6, 2024
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trialXuan Ying Poh, Anthony Torres-Ruesta, Terence Yoong, et al.
Ebiomedicine|August 13, 2024
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trialXuan Ying Poh, I Russel Lee, Chee Wah Tan, et al.
EMBO Molecular Medicine|January 7, 2022
Decreased memory B cell frequencies in COVID-19 delta variant vaccine breakthrough infectionMatthew Zirui Tay, Angeline Rouers, Siew-Wai Fong, et al.
The Lancet Regional Health. Western Pacific|May 1, 2023
Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variantMatthew Zirui Tay, Yun Shan Goh, Siew-Wai Fong, et al.
Journal of Medical Virology|October 28, 2022
Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boostersAngeline Rouers, Nathan Wong, Yun Shan Goh, et al.
Clinical & Translational Immunology|August 26, 2022
Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccineYun Shan Goh, Siew-Wai Fong, Angeline Rouers, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|July 19, 2023
Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBBZi Wei Chang, Yun Shan Goh, Angeline Rouers, et al.
The Journal of Infectious Diseases|November 23, 2023
Variant-Specific IgA Protects Against Omicron InfectionYun Shan Goh, Siew-Wai Fong, Pei Xiang Hor, et al.
Lancet (London, England)|August 22, 2020
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort studyBarnaby E Young, Siew-Wai Fong, Yi-Hao Chan, et al.
The Lancet Regional Health. Western Pacific|September 27, 2021
Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in AsiansBei Wang, Yun Shan Goh, Siew-Wai Fong, et al.
Vaccine|September 6, 2024
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trialXuan Ying Poh, Anthony Torres-Ruesta, Terence Yoong, et al.
Ebiomedicine|August 13, 2024
First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trialXuan Ying Poh, I Russel Lee, Chee Wah Tan, et al.
EMBO Molecular Medicine|January 7, 2022
Decreased memory B cell frequencies in COVID-19 delta variant vaccine breakthrough infectionMatthew Zirui Tay, Angeline Rouers, Siew-Wai Fong, et al.
The Lancet Regional Health. Western Pacific|May 1, 2023
Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variantMatthew Zirui Tay, Yun Shan Goh, Siew-Wai Fong, et al.
Journal of Medical Virology|October 28, 2022
Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boostersAngeline Rouers, Nathan Wong, Yun Shan Goh, et al.
Clinical & Translational Immunology|August 26, 2022
Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccineYun Shan Goh, Siew-Wai Fong, Angeline Rouers, et al.
Pageof 10